EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

5-HT1B receptor agonists promote Schwann cell myelination

Yuka Kobayashi-Ujiie, Keiko Hiraki-Kamon, Shuji Wakatsuki, Toshiyuki Araki iD

PLOS One · 27.03.2026 · 21 (3) · e0345946

DOI: 10.1371/journal.pone.0345946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 27.03.2026. Verfasst von Yuka Kobayashi-Ujiie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Schwann Cells, Myelin Sheath, Serotonin 5-HT1 Receptor Agonists, Receptor, Serotonin, 5-HT1B. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Dainippon Sumitomo Pharma, Masato Kawano Memorial Public Interest Foundation for Promotion of Pediatrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital demyelinating peripheral neuropathy causes severe sensorimotor defects, affecting patient mobility. To identify therapeutic compounds for peripheral hypomyelinating neuropathy, we performed an unbiased screening of annotated compound library by in vitro myelination culture model using Trembler (Tr-Ncnp) -derived dorsal root ganglia explants. Among the compounds identified in the screening, we confirmed that zolmitriptan, a 5-hydroxytryptamine 1B/1D receptor agonist, promotes myelination in culture. Zolmitriptan up-regulated myelin-related genes in primary Schwann cells and increased proliferating Schwann cells along axons in DRG explant cultures of Tr-Ncnp mice. Furthermore, we observed that chronic administration of zolmitriptan ameliorates sensorimotor dysfunction in Tr-Ncnp mice. Collectively, these results suggest that 5-HT1B/1D receptor agonists may increase Schwann cells participating in myelination, and consequently ameliorate myelination impairment in peripheral neuropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schwann CellsMyelin SheathSerotonin 5-HT1 Receptor AgonistsReceptor, Serotonin, 5-HT1BAnimalsMiceGanglia, SpinalCells, CulturedTryptamines

Substanzen

Serotonin 5-HT1 Receptor AgonistsReceptor, Serotonin, 5-HT1BTryptamines

Autor:innen und Institutionen

  • Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

ORCID-Profile: Toshiyuki Araki

Förderung

  • Japan Society for the Promotion of Science
  • Dainippon Sumitomo Pharma
  • Masato Kawano Memorial Public Interest Foundation for Promotion of Pediatrics
  • National Center of Neurology and Psychiatry

Zitieren

APA

Kobayashi-Ujiie, Y., Hiraki-Kamon, K., Wakatsuki, S., & Araki, T. (2026). 5-HT1B receptor agonists promote Schwann cell myelination. PLOS One, 21(3), e0345946. https://doi.org/10.1371/journal.pone.0345946

Vancouver

Kobayashi-Ujiie Y, Hiraki-Kamon K, Wakatsuki S, Araki T. 5-HT1B receptor agonists promote Schwann cell myelination. PLOS One. 2026;21(3):e0345946. doi:10.1371/journal.pone.0345946

BibTeX
@article{KobayashiUjiie2026,
  author = {Kobayashi-Ujiie, Yuka and Hiraki-Kamon, Keiko and Wakatsuki, Shuji and Araki, Toshiyuki},
  title = {5-HT1B receptor agonists promote Schwann cell myelination},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0345946},
  doi = {10.1371/journal.pone.0345946}
}
Kostenlos starten →